ATE229073T1 - Protein e25a, methoden zu dessen herstellung und anwendung - Google Patents

Protein e25a, methoden zu dessen herstellung und anwendung

Info

Publication number
ATE229073T1
ATE229073T1 AT97939804T AT97939804T ATE229073T1 AT E229073 T1 ATE229073 T1 AT E229073T1 AT 97939804 T AT97939804 T AT 97939804T AT 97939804 T AT97939804 T AT 97939804T AT E229073 T1 ATE229073 T1 AT E229073T1
Authority
AT
Austria
Prior art keywords
protein
cancer
nucleic acid
refractory prostate
hormone refractory
Prior art date
Application number
AT97939804T
Other languages
English (en)
Inventor
Robert E Reiter
Owen N Witte
Charles L Sawyers
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE229073T1 publication Critical patent/ATE229073T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97939804T 1996-09-06 1997-09-05 Protein e25a, methoden zu dessen herstellung und anwendung ATE229073T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2556996P 1996-09-06 1996-09-06
PCT/US1997/015606 WO1998010069A2 (en) 1996-09-06 1997-09-05 E25a PROTEIN, METHODS FOR PRODUCTION AND USE THEREOF

Publications (1)

Publication Number Publication Date
ATE229073T1 true ATE229073T1 (de) 2002-12-15

Family

ID=21826823

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97939804T ATE229073T1 (de) 1996-09-06 1997-09-05 Protein e25a, methoden zu dessen herstellung und anwendung

Country Status (7)

Country Link
US (2) US6093800A (de)
EP (1) EP0942972B1 (de)
AT (1) ATE229073T1 (de)
AU (1) AU4181897A (de)
CA (1) CA2265889A1 (de)
DE (1) DE69717664D1 (de)
WO (1) WO1998010069A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2221600A (en) 1998-12-31 2000-07-31 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
AU2487300A (en) * 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
JP4776075B2 (ja) 1998-12-31 2011-09-21 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 改変ｈｉｖｅｎｖポリペプチド
US7935805B1 (en) * 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
US6566078B1 (en) 1999-10-28 2003-05-20 Agensys, Inc. 36P6D5: secreted tumor antigen
AU2002227077A1 (en) * 2000-12-01 2002-06-11 Duke University Zinc alpha-2-glycoprotein as indicator of cancer
AU2002245108A1 (en) * 2000-12-15 2002-07-30 Origene Technologies, Inc. Angiogenesis gene and modulators
PT1573022E (pt) * 2001-04-10 2011-08-23 Agensys Inc Ácido nucleico e proteína correspondente intitulada 184p1e2, utilizadas para o tratamento e detecção de cancro
EP1411770A4 (de) * 2001-07-05 2006-05-10 Chiron Corp Polynukleotide, die für antigene hiv-polypeptide des c-typs codieren, polypeptide und ihre verwendung
EP2280074A3 (de) * 2001-07-05 2011-06-22 Novartis Vaccines and Diagnostics, Inc. Antigene typ-b- und/oder typ-c-hiv-polypeptide codierende polynukleotide, polypeptide und deren verwendungen
CA2458995C (en) * 2001-08-31 2013-04-30 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US20030170614A1 (en) * 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
US8507445B2 (en) * 2001-09-07 2013-08-13 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
US7671010B2 (en) * 2002-08-30 2010-03-02 The Board Of Regents Of The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
CA2496938A1 (en) * 2002-08-30 2004-03-11 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
PL2068918T5 (pl) 2006-09-26 2024-12-02 Access To Advanced Health Institute Kompozycja szczepionki zawierająca syntetyczny adiuwant
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
US20100129361A1 (en) * 2007-05-01 2010-05-27 The Brigham And Women's Hospital Immunosuppression with antibody against itm2a
CA2764374C (en) 2009-06-05 2019-11-19 Infectious Disease Research Institute Synthetic glucopyranosyl lipid adjuvants
EA027236B1 (ru) 2011-04-08 2017-07-31 Иммьюн Дизайн Корп. Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа
ES2729967T3 (es) 2012-02-07 2019-11-07 Infectious Disease Res Inst Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas
HRP20181102T1 (hr) 2012-05-16 2018-09-07 Immune Design Corp Cjepiva za hsv-2
MX370573B (es) 2013-04-18 2019-12-17 Immune Design Corp Monoterapia con glucopiranosil lipido a para usarse en el tratamiento del cancer.
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
IL310015B2 (en) 2013-12-31 2026-02-01 Access To Advanced Health Inst Single vial formulation
KR20250008135A (ko) 2016-06-01 2025-01-14 액세스 투 어드밴스드 헬스 인스티튜트 사이징제를 함유하는 나노명반 입자
WO2019051149A1 (en) 2017-09-08 2019-03-14 Infectious Disease Research Institute LIPOSOMAL FORMULATIONS COMPRISING SAPONIN AND METHODS OF USE
CA3141577A1 (en) 2019-05-25 2020-12-03 Infectious Disease Research Institute Composition and method for spray drying an adjuvant vaccine emulsion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69334071T2 (de) * 1992-11-05 2007-10-25 Sloan-Kettering Institute For Cancer Research Prostata-spezifisches membranantigen

Also Published As

Publication number Publication date
WO1998010069A2 (en) 1998-03-12
AU4181897A (en) 1998-03-26
EP0942972A2 (de) 1999-09-22
US7030232B1 (en) 2006-04-18
WO1998010069A3 (en) 1998-05-07
EP0942972B1 (de) 2002-12-04
CA2265889A1 (en) 1998-03-12
US6093800A (en) 2000-07-25
DE69717664D1 (de) 2003-01-16

Similar Documents

Publication Publication Date Title
ATE229073T1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
DE69926630D1 (de) Antikörper gegen die ed-b domäne von fibronektin, solche antikörper enthaltende konjugate, und deren verwendung zur diagnose und therapie von angiogenese-assoziierten tumoren und krankheiten
DE60134178D1 (de) Trp8 krebsmarker
CY1105212T1 (el) Αντισωματα αντι-april και κυτταρα υβριδωματος
WO2004110345A8 (en) Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
WO2004092338A3 (en) Compositions, splice variants and methods relating to cancer specific genes and proteins
DE69933989D1 (de) Biomarker und targets für die diagnose, prognose und behandlung von prostat krankheiten
ATE359515T1 (de) Proteinmarker für lungenkrebs und deren verwendung
PT991421E (pt) Deteccao e modulacao das iap e naip para o diagnostico e tratamento de doenca proliferativa
TR200103560T2 (tr) Göğüs kanserinin teşhis ve tedavisi için bileşimler ve bunların kullanımı
AU9021898A (en) Prostate tumor polynucleotide and antigen compositions
EP1578923A4 (de) Lösliche mic-polypeptide als marker zur diagnose, prognose und behandlung von krebs sowie autoimmunkrankheiten oder -erkrankungen
AR026946A1 (es) Osteoprotegerina/receptores de factores de necrosis de tumores
EP2263679A3 (de) Auf Proteine in Verbindung mit Krebs zielende RNAi-Sonde
WO2002031209A3 (en) Genes related to development of refractory prostate cancer
DE60032784D1 (de) Markerproteine für prostatakrebs
DE69633935D1 (de) Tumorenspezifisches p450 protein
EP1377596A4 (de) Ttk in der diagnose und als therapeutisches target bei krebs
DE69126038D1 (de) Diagnose von krebs-metastasen durch das mts-1 gen
DE60044350D1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
AP2000001917A0 (en) Gene encoding labyrinthin, a marker for cancer.
ATE277352T1 (de) Einetenascin-c isoform als marker für neoplasmen
DE60221115D1 (de) Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties